Risankizumab (Skyrizi)

What is risankizumab?

Risankizumab (Skyrizi) is an injectable biologic medication used in dermatology for moderate-to-severe plaque psoriasis and psoriatic arthritis. It is part of the IL-23 biologic class and is often considered for patients who need a systemic psoriasis treatment with less frequent maintenance injections.

It is commonly discussed as an option for patients who want a strong psoriasis treatment plan without very frequent ongoing injections.

How does risankizumab work?

Risankizumab targets interleukin-23 (IL-23), one of the inflammatory signals involved in psoriasis. By reducing IL-23 signaling, risankizumab can help calm the immune activity that drives thick, scaly plaques and ongoing skin inflammation.

Like other IL-23 biologics, it is aimed at a specific part of the psoriasis immune pathway rather than using older broad immunosuppressive strategies.

What are possible side effects of risankizumab?

Possible side effects can include:

  • Upper respiratory symptoms

  • Headache

  • Fatigue in some patients

  • Injection site reactions

As with other biologic medications, infection screening, vaccination review, and overall treatment risks should be discussed with the prescribing clinician. Patients should also review any chronic infection concerns or upcoming procedures before treatment starts.

How is risankizumab used?

Risankizumab is given by injection on a schedule directed by your provider. Some patients may be able to self-inject at home after appropriate training. The medication is stored in the refrigerator.

In dermatology, risankizumab is commonly discussed alongside other biologic options for patients who want a treatment plan that does not require very frequent maintenance injections. Prior treatment history, psoriatic arthritis symptoms, and insurance coverage can all affect whether it is the right fit.

THIS CONTENT IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES AND MAY NOT BE COMPREHENSIVE. IT DOES NOT CONSTITUTE MEDICAL ADVICE. PLEASE REFER TO OUR TERMS OF USE FOR FURTHER DETAILS. ALWAYS CONSULT WITH YOUR HEALTHCARE PROVIDER BEFORE MAKING ANY MEDICAL DECISIONS.